NCT02745899

Brief Summary

the investigators hypothesis is that milk consumption, either in the acute phase and through prolonged exposure, does not cause or increase respiratory symptoms or airway inflammation. the investigators aim to objectively prove this by examining respiratory symptoms and signs and objectively measuring parameters of airway inflammation and hyper responsiveness after consumption of cow milk or soy milk substitute.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable asthma

Timeline
Completed

Started May 2016

Shorter than P25 for not_applicable asthma

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 20, 2016

Completed
11 days until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

May 3, 2016

Status Verified

May 1, 2016

Enrollment Period

1 year

First QC Date

February 7, 2016

Last Update Submit

May 1, 2016

Conditions

Keywords

asthmacow milkpulmonary function testingchildrenmucus

Outcome Measures

Primary Outcomes (5)

  • Cough and mucus production according to patient's report and physical examination

    subjective report by the parents including: appearance of cough, rhinitis and objective physical examinations signs including: wheezing, rales, cough- yes or no

    Baseline

  • Cough and mucus production according to patient's report and physical examination

    subjective report by the parents including: appearance of cough, rhinitis and objective physical examinations signs including: wheezing, rales, cough- yes or no

    30 minutes after the intervention

  • Cough and mucus production according to patient's report and physical examination

    subjective report by the parents including: appearance of cough, rhinitis and objective physical examinations signs including: wheezing, rales, cough- yes or no

    60 minutes after the intervention

  • Cough and mucus production according to patient's report and physical examination

    subjective report by the parents including: appearance of cough, rhinitis and objective physical examinations signs including: wheezing, rales, cough- yes or no

    90 minutes after the intervention

  • Cough and mucus production according to patient's report and physical examination

    subjective report by the parents including: appearance of cough, rhinitis and objective physical examinations signs including: wheezing, rales, cough- yes or no

    120 minutes after the intervention

Secondary Outcomes (10)

  • Fraction of exhaled Nitric Oxide (FeNO)

    Baseline

  • Fraction of exhaled Nitric Oxide (FeNO)

    30 minutes after the intervention

  • Fraction of exhaled Nitric Oxide (FeNO)

    60 minutes after the intervention

  • Fraction of exhaled Nitric Oxide (FeNO)

    90 minutes after the intervention

  • Fraction of exhaled Nitric Oxide (FeNO)

    120 minutes after the intervention

  • +5 more secondary outcomes

Study Arms (4)

Soy milk substitute Healthy

ACTIVE COMPARATOR

Healthy children aged 6-18 will drink 240 ml of soy milk substitute.

Dietary Supplement: Soy milk

Soy milk substitute Asthma

ACTIVE COMPARATOR

Asthmatic children aged 6-18 will drink 240 ml of soy milk substitute.

Dietary Supplement: Soy milk

Cow milk Healthy

EXPERIMENTAL

Healthy children aged 6-18 will drink 240 ml of cow milk.

Dietary Supplement: Cow milk

Cow milk Asthma

EXPERIMENTAL

Asthmatic children aged 6-18 will drink 240 ml of cow milk.

Dietary Supplement: Cow milk

Interventions

Cow milkDIETARY_SUPPLEMENT

Ingestion of 240 ml cow milk

Cow milk AsthmaCow milk Healthy
Soy milkDIETARY_SUPPLEMENT

Ingestion of 240 ml soy milk

Soy milk substitute AsthmaSoy milk substitute Healthy

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Healthy children
  • Asthmatic children

You may not qualify if:

  • Known allergy to cow milk
  • Children had upper / lower respiratory disease in two weeks prior the study.
  • Children who had been treated in systemic steroids in the month prior the study.
  • Intolerant children to cow milk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Koren Y, Armoni Domany K, Gut G, Hadanny A, Benor S, Tavor O, Sivan Y. Respiratory effects of acute milk consumption among asthmatic and non-asthmatic children: a randomized controlled study. BMC Pediatr. 2020 Sep 12;20(1):433. doi: 10.1186/s12887-020-02319-y.

MeSH Terms

Conditions

Asthma

Interventions

MilkSoy Milk

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

BeveragesDiet, Food, and NutritionPhysiological PhenomenaDairy ProductsFoodFood and BeveragesMilk SubstitutesSoy FoodsVegetable ProductsVegetables

Study Officials

  • Keren Armoni Domany, Doctor

    Department of Pediatric Pulmonology, Critical Care and Sleep Medicine Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Keren Armoni Domany, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2016

First Posted

April 20, 2016

Study Start

May 1, 2016

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

May 3, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share